Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Sep;88(3):898–903. doi: 10.1172/JCI115392

Rapid alteration in circulating free thyroxine modulates pituitary type II 5' deiodinase and basal thyrotropin secretion in the rat.

S L Abend 1, S L Fang 1, S Alex 1, L E Braverman 1, J L Leonard 1
PMCID: PMC295477  PMID: 1885776

Abstract

TSH secretion is decreased by both T4 and T3. This negative feedback control of TSH secretion has been correlated with an increase in pituitary nuclear T3 content, and it is not clear whether T4 exerts its effect directly on the thyrotroph or after its deiodination to T3. However, levels of the pituitary enzyme catalyzing T4 to T3 conversion, 5'D-II, are decreased in the presence of an increased amount of T4. Thus, it is unclear why the thyrotroph would have a mechanism for modulating the production of T3, if T3 is, in fact, the sole bioactive signal providing negative feedback inhibition. To examine this apparent paradox, we administered EMD 21388, a compound which inhibits the binding of T4 to transthyretin resulting in a rapid increase in circulating free T4 levels, to rats pretreated with radiolabeled T4 and T3. We observed increases in pituitary and liver T4 content of greater than 150%, without increases in the respective tissue T3 contents. The EMD 21388-treated rats also exhibited a 25% decrease in pituitary 5'D-II activity (103.8 +/- 15.8 fmol 125I released.mg protein-1.h-1, vs. control, 137.4 +/- 15.9, mean +/- SE), as did rats treated with sodium salicylate, another compound that inhibits T4-TTR binding (100.8 +/- 7.1). TSH levels significantly decreased 2 h after the administration of EMD 21388. These data demonstrate that despite a T4-mediated decrease in pituitary 5'D-II activity, an increase in T4 independently decreases TSH secretion.

Full text

PDF
898

Images in this article

900Image
on p.900

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellabarba D., Peterson R. E., Sterling K. An improved method for chromatography of iodothyronines. J Clin Endocrinol Metab. 1968 Feb;28(2):305–307. doi: 10.1210/jcem-28-2-305. [DOI] [PubMed] [Google Scholar]
  2. Cheron R. G., Kaplan M. M., Larsen P. R. Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. J Clin Invest. 1979 Nov;64(5):1402–1414. doi: 10.1172/JCI109598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis P. J., Spaulding S. W., Gregerman R. I. The three thyroxine-binding proteins in rat serum: binding capacities and effects of binding inhibitors. Endocrinology. 1970 Nov;87(5):978–986. doi: 10.1210/endo-87-5-978. [DOI] [PubMed] [Google Scholar]
  4. Emerson C. H., Lew R., Braverman L. E., DeVito W. J. Serum thyrotropin concentrations are more highly correlated with serum triiodothyronine concentrations than with serum thyroxine concentrations in thyroid hormone-infused thyroidectomized rats. Endocrinology. 1989 May;124(5):2415–2418. doi: 10.1210/endo-124-5-2415. [DOI] [PubMed] [Google Scholar]
  5. Farwell A. P., Leonard J. L. Identification of a 27-kDa protein with the properties of type II iodothyronine 5'-deiodinase in dibutyryl cyclic AMP-stimulated glial cells. J Biol Chem. 1989 Dec 5;264(34):20561–20567. [PubMed] [Google Scholar]
  6. Good B. F., Hetzel B. S., Hogg B. M. Studies of the control of thyroid function in rats: effects of salicylate and related drugs. Endocrinology. 1965 Oct;77(4):674–682. doi: 10.1210/endo-77-4-674. [DOI] [PubMed] [Google Scholar]
  7. Goswami A., Rosenberg I. N. Regulation of iodothyronine 5'-deiodinases: effects of thiol blockers and altered substrate levels in vivo and in vitro. Endocrinology. 1990 May;126(5):2597–2606. doi: 10.1210/endo-126-5-2597. [DOI] [PubMed] [Google Scholar]
  8. Koenig R. J., Leonard J. L., Senator D., Rappaport N., Watson A. Y., Larsen P. R. Regulation of thyroxine 5'-deiodinase activity by 3,5,3'-triiodothyronine in cultured rat anterior pituitary cells. Endocrinology. 1984 Jul;115(1):324–329. doi: 10.1210/endo-115-1-324. [DOI] [PubMed] [Google Scholar]
  9. Koenig R. J. Regulation of thyroxine 5'-deiodinase by thyroid hormones and activators of protein kinase C in GH4C1 cells. Endocrinology. 1986 Apr;118(4):1491–1497. doi: 10.1210/endo-118-4-1491. [DOI] [PubMed] [Google Scholar]
  10. Köhrle J., Fang S. L., Yang Y., Irmscher K., Hesch R. D., Pino S., Alex S., Braverman L. E. Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinology. 1989 Jul;125(1):532–537. doi: 10.1210/endo-125-1-532. [DOI] [PubMed] [Google Scholar]
  11. Larsen P. R., Dick T. E., Markovitz B. P., Kaplan M. M., Gard T. G. Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. J Clin Invest. 1979 Jul;64(1):117–128. doi: 10.1172/JCI109430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Larsen P. R., Frumess R. D. Comparison of the biological effects of thyroxine and triiodothyronine in the rat. Endocrinology. 1977 Apr;100(4):980–988. doi: 10.1210/endo-100-4-980. [DOI] [PubMed] [Google Scholar]
  13. Larsen P. R. Salicylate-induced increases in free triiodothyronine in human serum. Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin. J Clin Invest. 1972 May;51(5):1125–1134. doi: 10.1172/JCI106905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Leonard J. L., Silva J. E., Kaplan M. M., Mellen S. A., Visser T. J., Larsen P. R. Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5'-deiodinases by thyroid hormone. Endocrinology. 1984 Mar;114(3):998–1004. doi: 10.1210/endo-114-3-998. [DOI] [PubMed] [Google Scholar]
  15. Lueprasitsakul W., Alex S., Fang S. L., Pino S., Irmscher K., Köhrle J., Braverman L. E. Flavonoid administration immediately displaces thyroxine (T4) from serum transthyretin, increases serum free T4, and decreases serum thyrotropin in the rat. Endocrinology. 1990 Jun;126(6):2890–2895. doi: 10.1210/endo-126-6-2890. [DOI] [PubMed] [Google Scholar]
  16. Lum S. M., Nicoloff J. T., Spencer C. A., Kaptein E. M. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J Clin Invest. 1984 Feb;73(2):570–575. doi: 10.1172/JCI111245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Maeda M., Ingbar S. H. Effect of alterations in thyroid status on the metabolism of thyroxine and triiodothyronine by rat pituitary gland in vitro. J Clin Invest. 1982 Apr;69(4):799–808. doi: 10.1172/JCI110519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maruta S., Greer M. A. Evidence that thyroxine inhibits either basal or TRH-induced TSH secretion only after conversion to triiodothyronine. Proc Soc Exp Biol Med. 1988 Apr;187(4):391–397. doi: 10.3181/00379727-187-42679. [DOI] [PubMed] [Google Scholar]
  19. Morley J. E. Neuroendocrine control of thyrotropin secretion. Endocr Rev. 1981 Fall;2(4):396–436. doi: 10.1210/edrv-2-4-396. [DOI] [PubMed] [Google Scholar]
  20. Navab M., Smith J. E., Goodman D. S. Rat plasma prealbumin. Metabolic studies on effects of vitamin A status and on tissue distribution. J Biol Chem. 1977 Jul 25;252(14):5107–5114. [PubMed] [Google Scholar]
  21. Obregon M. J., Pascual A., Mallol J., Morreale de Escobar G., Escobar del Rey F. Evidence against a major role of L-thyroxine at the pituitary level: studies in rats treated with iopanoic acid (telepaque). Endocrinology. 1980 Jun;106(6):1827–1836. doi: 10.1210/endo-106-6-1827. [DOI] [PubMed] [Google Scholar]
  22. Silva J. E., Dick T. E., Larsen P. R. The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology. 1978 Oct;103(4):1196–1207. doi: 10.1210/endo-103-4-1196. [DOI] [PubMed] [Google Scholar]
  23. Silva J. E., Larsen P. R. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. J Clin Invest. 1978 May;61(5):1247–1259. doi: 10.1172/JCI109041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Silva J. E., Larsen P. R. Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 1977 Nov 11;198(4317):617–620. doi: 10.1126/science.199941. [DOI] [PubMed] [Google Scholar]
  25. Silva J. E., Leonard J. L. Regulation of rat cerebrocortical and adenohypophyseal type II 5'-deiodinase by thyroxine, triiodothyronine, and reverse triiodothyronine. Endocrinology. 1985 Apr;116(4):1627–1635. doi: 10.1210/endo-116-4-1627. [DOI] [PubMed] [Google Scholar]
  26. Surks M. I., DeFesi C. R. Determination of the cell number of each cell type in the anterior pituitary of euthyroid and hypothyroid rats. Endocrinology. 1977 Sep;101(3):946–958. doi: 10.1210/endo-101-3-946. [DOI] [PubMed] [Google Scholar]
  27. Visser T. J., Kaplan M. M., Leonard J. L., Larsen P. R. Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J Clin Invest. 1983 Apr;71(4):992–1002. doi: 10.1172/JCI110854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Weeke J., Orskov H. Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay. Scand J Clin Lab Invest. 1973 Dec;32(4):357–360. doi: 10.3109/00365517309084359. [DOI] [PubMed] [Google Scholar]
  29. Young R. A., Danforth E., Jr, Vagenakis A. G., Krupp P. P., Frink R., Sims E. A. Seasonal variation and the influence of body temperature on plasma concentrations and binding of thyroxine and triiodothyronine in the woodchuck. Endocrinology. 1979 Apr;104(4):996–999. doi: 10.1210/endo-104-4-996. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES